Sort
82,697 grants matching “vaccine development”
Zika virus pathophysiology during pregnancy
$2,020,452David H Oconnor · University Of Wisconsin-Madison · P01 · FY2022 · AI
Zika virus pathophysiology during pregnancy
$2,020,451David H Oconnor · University Of Wisconsin-Madison · P01 · FY2020 · AI
Immunopathogenesis of Acute HIV-1 Infection
$2,020,340University Of Colorado Denver · P01 · FY2005 · AI
Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
$2,019,826Peter Rice · Univ Of Massachusetts Med Sch Worcester · N01 · FY2020 · AI
Structure-function studies of alpha-and flaviviruses
$2,019,501Purdue University West Lafayette · P01 · FY2003 · AI
Correlates of protective immunity to HCV and rational vaccine design
$2,018,828Arash Grakoui · Emory University · U19 · FY2021 · AI
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$2,018,756Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Lifespan/Tufts/brown Center for AIDS Research (CFAR)
$2,018,753Susan Cu-Uvin · Miriam Hospital · P30 · FY2015 · AI
Shaping Antiviral Immunity by the Inflammatory, Regulatory and Tissue Environment
$2,018,324E. John Wherry · University Of Pennsylvania · U19 · FY2012 · AI
Adjuvant Development of the TLR4 Ligand BECC470s For Use in Influenza, S. aureus, and P. aeruginosa Vaccines
$2,018,199Gregory Sorenson · University Of Maryland Baltimore · N01 · FY2025 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,018,048David S Stephens · Emory University · UM1 · FY2022 · AI
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
$2,017,824Rhea N Coler · Access To Advanced Health Institute · U01 · FY2010 · AI
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
$2,017,261Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$2,017,142Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Units for HIV/AIDS Clinical Trials Networks
$2,016,531Ram Yogev · Lurie Children'S Hospital Of Chicago · U01 · FY2008 · AI
Immunology Core
$2,016,247Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2014 · AI
Immunology Core
$2,016,247Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2015 · AI
KwaZulu-Natal Clinical Trials Unit
$2,015,382Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2025 · AI
Kaiser Washington Vaccine and Treatment Evaluation Unit - DMID 21-0012
$2,014,564Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses
$2,014,259Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$2,014,197Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
University of Rochester Center for AIDS Research
$2,014,115Stephen Dewhurst · University Of Rochester · P30 · FY2016 · AI
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants
$2,013,897Dixon B Kaufman · University Of Wisconsin-Madison · U01 · FY2012 · AI
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
$2,013,333Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2023 · AI
Developmental and Mentoring Core
$2,012,828Ingrid Valerie Bassett · Harvard University · P30 · FY2022 · AI